Martín-Villalba, A., & Krammer, P. H. (2002). Inhibition of TNF and CD95(APO-1/Fas) ligand as a novel therapy for stroke. Emirates medical journal, 20, .
Chicago-Zitierstil (17. Ausg.)Martín-Villalba, Ana, und Peter H. Krammer. "Inhibition of TNF and CD95(APO-1/Fas) Ligand as a Novel Therapy for Stroke." Emirates Medical Journal 20 (2002).
MLA-Zitierstil (9. Ausg.)Martín-Villalba, Ana, und Peter H. Krammer. "Inhibition of TNF and CD95(APO-1/Fas) Ligand as a Novel Therapy for Stroke." Emirates Medical Journal, vol. 20, 2002.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.